56 studies on Selank curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab indexes 1,589 published Selank COA source records from third-party laboratories, covering 636 publicly attributable vendor identities. Across 1,434 records with positive numeric purity, the arithmetic mean is 99.66%. 0 records report zero purity; these remain in the record count and are excluded from the positive-purity mean. 1 positive purity results are below 90%; 50 records report measured amount more than 10% below the label. The latest recorded test date is 2026-10-13. TitrateLab did not perform these laboratory tests. Source records are not unique batches, and vendor identity does not establish manufacturing role, product safety or overall quality.
As of 2026-10-18, vendor-blind retail asking-price averages for the US delivery market, calculated from the same in-stock exact-strength cells as the Peptide Price Index. Shipping is excluded.
| Strength | Average / vial | Observed range / vial | Average / mg | Coverage |
|---|---|---|---|---|
| 5 mg | $6.00 | $5.00–$6.50 | $1.20 | 3 sources · 3 offers |
| 10 mg | $10.38 | $9.00–$13.00 | $1.04 | 4 sources · 4 offers |
| 30 mg | $16.00 | $16.00–$16.00 | $0.53 | 1 source · 1 offer |
Asking prices are not manufacturing cost and do not establish product equivalence, quality, safety, or legality. View full price methodology →
All published source records, including absent and zero purity. Matching uses a case-insensitive exact peptide token. No deduplication in the headline; vendor rankings deduplicate eligible certificates separately. The COA archive can use normalized compound names and a different measurement or duplicate policy; totals from these populations need not match.
Latest recorded test: 2026-10-13. Aggregate calculated: 2026-10-18T10:34:21.883130+00:00. Calculation time is not a laboratory observation date.
Within that total, 483 source records have unresolved vendor identity. They remain in corpus-level lab evidence and are excluded from named-vendor rankings.
Eligible vendors have at least 2 deduplicated certificates and 2 classifiable identity observations. Rank uses the 95% lower confidence bound on clean identity results; mean positive purity and certificate count break ties. Missing measurements are not passes. Exact-zero/not-detected and explicit wrong-compound markers count once per adverse certificate. This describes submitted-sample evidence, not every product or shipment, and is not an endorsement.
| Rank | Vendor | Deduplicated certificates | Avg positive purity | Identity adverse results | |
|---|---|---|---|---|---|
| #1 | 27 | 99.6% | 0 of 22 (0.0%) 0 0% / not detected · 0 wrong compound · 5 unclassified | Reveal with Pro → | |
| #2 | 14 | 99.78% | 0 of 14 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #3 | 14 | 99.67% | 0 of 13 (0.0%) 0 0% / not detected · 0 wrong compound · 1 unclassified | Reveal with Pro → |
Vendor identities are included with Pro. Record counts and lab measurements remain visible.
Recent source records: #119528 (99.65%) · #120555 (99.73%) · #119232 (99.47%) · #120192 (99.47%) · #119667 (99.03%) · #119613 (99.77%)
This research highlights Selank's potential as a therapeutic agent for mitigating stress-induced gastrointestinal pathology. By reducing systemic stress markers like corticosterone and directly improving colonic morph…
The upstream classifier incorrectly tagged this paper as being related to the peptide **Selank**. The research provides no information, directly or indirectly, about Selank's properties, mechanisms, or potential appli…
This research suggests that Selank could be a promising novel therapeutic candidate for managing the distressing and often debilitating symptoms of opioid withdrawal, offering a potential non-opioid alternative. Its a…
This research significantly advances our understanding of the molecular basis of umami taste, particularly through the novel mechanism of peptide mineral chelates. The identification of specific potent umami peptides …
Precise chemical characterization is fundamental for any therapeutic agent, ensuring reproducibility in research and safety in potential clinical applications. Understanding Selank's exact molecular structure allows f…
If this study reveals positive findings, it could significantly expand our understanding of non-pharmacological interventions for cognitive enhancement. Demonstrating that balance exercises, whether traditional or gam…
Free, no account — handy when you're working with Selank.
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$14 monthly or $88/year
Create an account